CYTOMED THERAPEUTICS LTD (GDTC) Earnings History & Surprises

NASDAQ:GDTC • SGXZ17669631

1.06 USD
+0.01 (+0.97%)
At close: Mar 4, 2026
1.0203 USD
-0.04 (-3.75%)
After Hours: 3/4/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for CYTOMED THERAPEUTICS LTD (GDTC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateApr 28, 2026
PeriodQ3 / 2025
EPS Estimate-SGD0.04
Revenue Estimate132.6K

Last Reported

Most Recent
Release DateNov 14, 2025
PeriodQ2 / 2025
EPS Reported
EPS Surprise %
Revenue Surprise 17.57%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (SGD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2025 -0.04 - -33.33% 155.9K 132.6K 17.57% -
Q1 2025 -0.04 - -33.33% 132.6K - -16.67%
Q4 2024 -0.04 - 20.00% 69.5K 132.6K -47.59% -
Q3 2024 -0.04 - 20.00% 132.6K - -
Q2 2024 -0.03 - 62.50% 159.12K -100.00% -
Q1 2024 -0.03 - 62.50% 159.12K - 20.00%
Q4 2023 -0.05 - - 132.6K -100.00% -
Q3 2023 -0.05 - - 132.6K - -
Q2 2023 -0.08 - - 132.6K -100.00% -
Q1 2023 -0.08 - - 132.6K - -
Q4 2022 - - - -
Q2 2022 - - - -
Q4 2021 - - - -
Q2 2021 - - - -
Q4 2020 - - - -
Q2 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

GDTC EPS Q2Q GrowthGDTC EPS Q2Q GrowthEPS Q2Q Growth Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 0 20 -20 40 60

Revenue Historical Q2Q growth and Acceleration

GDTC Revenue Q2Q GrowthGDTC Revenue Q2Q GrowthRevenue Q2Q Growth Q1/24 Q3/24 Q1/25 Q3/25 Q4/25 0 20 40 60 80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

Related analysis

GDTC Overview GDTC Technical Analysis Report GDTC Fundamental Analysis Report GDTC Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

CYTOMED THERAPEUTICS LTD / GDTC Earnings FAQ

Can you provide the last earnings date for CYTOMED THERAPEUTICS LTD?

CYTOMED THERAPEUTICS LTD (GDTC) last reported earnings on 11/14/2025.


Did GDTC stock beat earnings estimates in the most recent quarter?

CYTOMED THERAPEUTICS LTD (GDTC) missed EPS estimates and beat revenue estimates in the most recent quarter.